Researchers assessed changes in the prevalence of diversity language in NIH-awarded grants following the US election in 2024.

Significant treatment options are changing the management of CLL, according to research presented at the ASH Annual Meeting 2025.

In this study, researchers aimed to determine whether ctDNA is detectable in other bodily fluids besides blood, and to characterize any ctDNA they were able to detect.

The Food and Drug Administration (FDA) has granted traditional approval to Imdelltra ® (tarlatamab-dlle) for the treatment of adults with extensive stage small cell lung cancer (ES-SCLC) with disease ...

In this study, researchers sought to determine the impact of the FDA’s Accelerated Approval pathway among patients with solid tumors.

Use of tanning beds more than doubles the risk of developing melanoma by increasing the mutation burden in melanocytes, including at skin sites with ...

Overall survival data showed a 50% reduction in the risk of death with the regimen compared with surgery alone.

The current study assesses whether the MNW could address global disparities in oncology education by reaching low- and middle-income countries and if it was able to advance gender inclusivity in ...

Cancer patients and survivors are more likely to report housing and utility insecurity than those who do not have a history of cancer, according research ...

The latest data released at ASH 2025 offer new combination therapies for the treatment of multiple myeloma and new insights into the disease.

(HealthDay News) — For women with a history of breast cancer, real (RA) and sham acupuncture (SA) produce clinically meaningful improvements in perceived cognitive impairment, according to a study ...

Following the expanded approval, the accelerated approval for the later-line CLL/SLL was converted to a traditional approval.